Suchergebnisse - "Porter, Stephen"

PubPharm (10)

1

Intestinal Persistence of Colonizing Escherichia coli Strains, Especially ST131-H30, in Relation to Bacterial and Host Factors

enthalten in: The Journal of infectious diseases | 2022

von Johnson, J. | Clabots, C. | Porter, S. | +3

2

Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, blaCTX-M genotype, and resistance to comparator agents

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2021

von Johnston, B. | Thuras, P. | Porter, S. | +2

3

Activity of plazomicin against carbapenem-intermediate or -resistant Escherichia coli isolates from the United States and international sites in relation to clonal background, resistance genes, co-resistance, and region

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Johnston, B. | Thuras, P. | Porter, S. | +6

4

Molecularly defined extraintestinal pathogenic Escherichia coli status predicts virulence in a murine sepsis model better than does virotype, individual virulence genes, or clonal subset among E. coli ST131 isolates

enthalten in: Virulence | 2020

von Merino, I. | Porter, S. | Johnston, B. | +5

5

Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region

enthalten in: Antimicrobial agents and chemotherapy | 2020

von Johnston, B. | Thuras, P. | Porter, S. | +6

6

Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region

enthalten in: Antimicrobial agents and chemotherapy | 2020

von Johnston, B. | Thuras, P. | Porter, S. | +6

7

Clinical and Molecular Correlates of Escherichia coli Bloodstream Infection from Two Geographically Diverse Centers in Rochester, Minnesota, and Singapore

enthalten in: Antimicrobial agents and chemotherapy | 2018

von Mendis, S. | Vasoo, S. | Johnston, B. | +8

8

Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans

enthalten in: Antimicrobial agents and chemotherapy | 2016

von Mohamed, M. | Clabots, C. | Porter, S. | +2

9

Extensive Household Outbreak of Urinary Tract Infection and Intestinal Colonization due to Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2015

von Madigan, T. | Johnson, J. | Clabots, C. | +4

10

Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010

enthalten in: Antimicrobial agents and chemotherapy | 2013

von Banerjee, R. | Robicsek, A. | Kuskowski, M. | +6

1
[1]